anantatech.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.anantatech.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title Home | Ananta
Description Ananta (Sanskrit: अनन्त) [uh-nahn-tuh]: top of page Home The CentriFLEX Our Team Contact Us ANANTA TECHNOLOGIES Limitless solutions. Ananta (Sanskrit: अनन्त) [uh-nahn-tuh]: limitless. The Centri
Keywords N/A
Server Information
WebSite anantatech faviconanantatech.com
Host IP 185.230.63.171
Location -
Related Websites
Site Rank
More to Explore
anantatech.com Valuation
US$1,365
Last updated: 2023-05-20 07:13:50

anantatech.com has Semrush global rank of 0. anantatech.com has an estimated worth of US$ 1,365, based on its estimated Ads revenue. anantatech.com receives approximately 157 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, anantatech.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,365
Daily Ads Revenue US$1
Monthly Ads Revenue US$37
Yearly Ads Revenue US$453
Daily Unique Visitors 10
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
anantatech.com. A 3600 IP: 185.230.63.171
anantatech.com. A 3600 IP: 185.230.63.107
anantatech.com. A 3600 IP: 185.230.63.186
anantatech.com. NS 86400 NS Record: ns0.wixdns.net.
anantatech.com. NS 86400 NS Record: ns1.wixdns.net.
anantatech.com. MX 3600 MX Record: 0 anantatech-com.mail.protection.outlook.com.
HtmlToTextCheckTime:2023-05-20 07:13:50
top of page Home The CentriFLEX Our Team Contact Us ANANTA TECHNOLOGIES Limitless solutions. Ananta (Sanskrit: अनन्त) [uh-nahn-tuh]: limitless. The CentriFLEX Meet The CentriFLEX. Our vision is to increase adoption of cell therapies by creating limitless solutions for biologics manufacturing. Cancer remains a leading cause of death worldwide, and it is estimated that U.S. cancer patients paid $16.2 billion out of pocket for cancer care in 2019, with costs continuing to rise. We are familiar with the adverse side effects of more readily available treatments such as radiation and chemotherapy, and extensive evidence shows promising results with immunotherapy because of its ability to fight cancer cells without harming healthy tissue in the body. The general idea in immunotherapy is to isolate the T cell immune response, a specific kind of white blood cell, from a cancer patient’s blood sample, expand them to high numbers in a lab or manufacturing facility, and reintroduce them to the
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 21 Jan 2023 09:04:30 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.anantatech.com/
strict-transport-security: max-age=3600
Age: 70446
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=84
X-Seen-By: RQvnDyN5n1orR2cJk2hJbg==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgkyCy5tpIRlB6WbEIvaaiO,m0j2EEknGIVUW/liY8BLLtxbqKixcgheJzihIl22fmTJftmKrOReD3ukbbas4YDo,2d58ifebGbosy5xc+FRalrgTRyHrgAdecuW6MZNY2/6C92ka/6p7apwIHhI7+z0sy3Sygutts5KkpHuNh6D5aw==,2UNV7KOq4oGjA5+PKsX47NkbCs7NWzOa7Lk4dAE/5sG8ZDY613cHYLbuhNMgAom1
Cache-Control: no-cache
X-Wix-Request-Id: 1674291870.82739793847123341
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 21 Jan 2023 09:04:31 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1674291870.9705254509416503
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMeeA0mLzwUrMx5Itcz9Xesf,qquldgcFrj2n046g4RNSVIrig9SAqnXW0O7zAzsQkQs=,2d58ifebGbosy5xc+FRaltZvS3t4wxGkBEQhGsc6FeIjF14tea/yqfUMpPTJDZcFGLC2TD/UgrnlY2mEQHTqyxto2UTyMzrxqUtKHm0zxsw=,2UNV7KOq4oGjA5+PKsX47PpAuGwGFDWggbLa+hP4SSpWd3xniMsr1HjrszKGvMzr,7npGRUZHWOtWoP0Si3wDp7zT5RIk4Gbggt5/mHmXvRE=,m86p0LbwQP79i4nFFg3YpkkTZv72hogh6h9s44SivJR1iqMTqgSixErDL2rfoiYeiLmOBCJX9PwPq0FFNfh5cw==,xTu8fpDe3EKPsMR1jrheEDb/jGovqN0k6dreWxRDvuw=,LoUK8/saGAmOxZWtpubo2leTAIKm/bEWaMRniwm9S9zCZ4Iw6aQgO2AF79WSqOSkL8a6QrO2pkZsh5zOm79Kpg==,xTu8fpDe3EKPsMR1jrheECjxRVYXPLLVkj6KiuuJzI4=,xTu8fpDe3EKPsMR1jrheEK6jzadKxJcjY1VK+XzpfzU=,/a5ccLSK1HEmwPNg/x6OuhwVf+M/llv4ecAdPJ9TQievySVkiUnv569vqef86lFl4l8EsHcI0l2fxMWCOnp7PA==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=euw3_g; Max-Age=20; Expires=Sat, 21 Jan 2023 09:04:51 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=euw3_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"